FAV-201 Uses, Dosage, Side Effects and more
FAV-201 is a patient-specific immunotherapy for the treatment of T-cell lymphoma.
FAV-201 is a recombinant, patient-specific, T-cell receptor-based immunotherapy designed to induce an active immune response against the unique protein found on the surface of T-cells that constitute a patient's lymphoma.
| Trade Name | FAV-201 |
| Generic | FAV-201 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in lymphoma (non-hodgkin's).
